---
schema_version: "secwatch.filing_event.v1"
accession: "0001425450-23-000092"
form_type: "8-K"
ticker: "KIDS"
cik: "0001425450"
company_name: "ORTHOPEDIATRICS CORP"
filed_at: "2023-06-16T23:59:59+00:00"
generated_at: "2026-06-13T22:30:09.719224+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# All four stockholder proposals approved at OrthoPediatrics 2023 annual meeting

## Summary
- Directors elected: Dyer (20.2M for), Pelizzon (15.7M for, 4.7M withheld), Ruf (15.7M for), Schlotterback (14.4M for).
- Advisory say-on-pay approved with 19.2M for, 1.1M against, 60.9K abstain.
- Stockholders recommended annual say-on-pay frequency (11.3M votes for 1 year vs 8.8M for 3 years).
- Deloitte & Touche ratified as independent auditor for FY2023 with 21.3M for, 21.6K against.

## SEC filing metadata
- accession: 0001425450-23-000092
- form_type: 8-K
- ticker: KIDS
- cik: 0001425450
- company_name: ORTHOPEDIATRICS CORP
- filed_at: 2023-06-16T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1425450/000142545023000092/0001425450-23-000092-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1425450/000142545023000092/kids-20230614.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001425450-23-000092
- JSON: https://secwatch.observer/filing/0001425450-23-000092.json
- Plain text: https://secwatch.observer/filing/0001425450-23-000092.txt

## Key facts
- Shareholder Votes
  ORTHOPEDIATRICS CORP shareholders approved Election of Directors at the 2023-06-14 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-14
  source text: The nominees below were elected to serve as directors for a term that will last until the Company’s 2026 Annual Meeting of Stockholders or until his successor is duly elected and qualified.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1425450/000142545023000092/0001425450-23-000092-index.htm
- Shareholder Votes
  ORTHOPEDIATRICS CORP shareholders approved Approval, on an advisory basis, of the compensation of the Company's named executive officers at the 2023-06-14 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2023-06-14
  source text: The Company's stockholders approved the compensation of the Company's named executive officers by voting as follows: For Against Abstain Broker Non-Votes 19,169,777 1,077,595 60,927 981,776
  evidence_url: https://www.sec.gov/Archives/edgar/data/1425450/000142545023000092/0001425450-23-000092-index.htm
- Shareholder Votes
  ORTHOPEDIATRICS CORP shareholders approved Selection, on an advisory basis, of the frequency of future advisory votes on executive compensation at the 2023-06-14 meeting.
  - Proposal: say on pay frequency
  - Outcome: passed
  - Meeting: 2023-06-14
  source text: As reflected below, a majority of the votes cast advised that the vote on executive compensation should occur every year.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1425450/000142545023000092/0001425450-23-000092-index.htm
- Shareholder Votes
  ORTHOPEDIATRICS CORP shareholders approved Approval, on an advisory basis, of the appointment of Deloitte & Touche LLP as the Company’s Independent Registered Public Accounting Firm for our Fiscal Year Ending December 31, 2023 at the 2023-06-14 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-14
  source text: The Company’s stockholders approved the appointment by the Audit Committee of the Company’s Board of Directors of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023 by voting as follows: For Against Abstain 21,268,308 21,630 137
  evidence_url: https://www.sec.gov/Archives/edgar/data/1425450/000142545023000092/0001425450-23-000092-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.